Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Santagostino

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Thrombosis Research|June 12, 2016
Transforming the treatment for hemophilia B patients: update on the clinical development of recombinant fusion protein linking recombinant coagulation factor IX with recombinant albumin (rIX-FP)Elena Santagostino
Thrombosis Research|March 30, 2013
PROLONG-9FP clinical development program--phase I results of recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP)Elena Santagostino
Drug Design, Development and Therapy|December 31, 2014
A new recombinant factor VIII: from genetics to clinical useElena Santagostino
Journal of Clinical Medicine|March 29, 2017
Outcome of Clinical Trials with New Extended Half-Life FVIII/IX ConcentratesMaria Elisa Mancuso, Elena Santagostino
British Journal of Haematology|April 19, 2017
Platelets: much more than bricks in a breached wallMaria Elisa Mancuso, Elena Santagostino
Drug Design, Development and Therapy|September 27, 2018
GlycoPEGylated recombinant factor IX for hemophilia B in contextElena Santagostino, Maria Elisa Mancuso
Blood Transfusion = Trasfusione Del Sangue|December 25, 2008
Barriers to primary prophylaxis in haemophilic children: the issue of the venous accessElena Santagostino, Maria Elisa Mancuso
Seminars in Thrombosis and Hemostasis|September 10, 2013
Hemophilia a and hemophilia B: different types of diseases?Elena Santagostino, Maria Rosaria Fasulo
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 30, 2020
Invasive procedures in patients with haemophilia: Review of low-dose protocols and experience with extended half-life FVIII and FIX concentrates and non-replacement therapiesCedric Hermans, Shashikant Apte, Elena Santagostino
Paediatric Drugs|March 23, 2002
State of care for hemophilia in pediatric patientsElena Santagostino, Alessandro Gringeri, Pier M Mannucci
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Thrombosis Research|June 12, 2016
Transforming the treatment for hemophilia B patients: update on the clinical development of recombinant fusion protein linking recombinant coagulation factor IX with recombinant albumin (rIX-FP)Elena Santagostino
Thrombosis Research|March 30, 2013
PROLONG-9FP clinical development program--phase I results of recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP)Elena Santagostino
Drug Design, Development and Therapy|December 31, 2014
A new recombinant factor VIII: from genetics to clinical useElena Santagostino
Journal of Clinical Medicine|March 29, 2017
Outcome of Clinical Trials with New Extended Half-Life FVIII/IX ConcentratesMaria Elisa Mancuso, Elena Santagostino
British Journal of Haematology|April 19, 2017
Platelets: much more than bricks in a breached wallMaria Elisa Mancuso, Elena Santagostino
Drug Design, Development and Therapy|September 27, 2018
GlycoPEGylated recombinant factor IX for hemophilia B in contextElena Santagostino, Maria Elisa Mancuso
Blood Transfusion = Trasfusione Del Sangue|December 25, 2008
Barriers to primary prophylaxis in haemophilic children: the issue of the venous accessElena Santagostino, Maria Elisa Mancuso
Seminars in Thrombosis and Hemostasis|September 10, 2013
Hemophilia a and hemophilia B: different types of diseases?Elena Santagostino, Maria Rosaria Fasulo
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 30, 2020
Invasive procedures in patients with haemophilia: Review of low-dose protocols and experience with extended half-life FVIII and FIX concentrates and non-replacement therapiesCedric Hermans, Shashikant Apte, Elena Santagostino
Paediatric Drugs|March 23, 2002
State of care for hemophilia in pediatric patientsElena Santagostino, Alessandro Gringeri, Pier M Mannucci
Pageof 17